353 related articles for article (PubMed ID: 26187311)
1. Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.
Thériault O; Poulin H; Beaulieu JM; Chahine M
Eur J Pharmacol; 2015 Oct; 764():395-403. PubMed ID: 26187311
[TBL] [Abstract][Full Text] [Related]
2. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.
Thériault O; Poulin H; Sculptoreanu A; de Groat WC; O'Leary ME; Chahine M
Eur J Pharmacol; 2014 Mar; 727():158-66. PubMed ID: 24486399
[TBL] [Abstract][Full Text] [Related]
3. Antidepressants inhibit Na
Horishita T; Yanagihara N; Ueno S; Okura D; Horishita R; Minami T; Ogata Y; Sudo Y; Uezono Y; Sata T; Kawasaki T
Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1255-1270. PubMed ID: 28905186
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine blocks Nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmics.
Poulin H; Bruhova I; Timour Q; Theriault O; Beaulieu JM; Frassati D; Chahine M
Mol Pharmacol; 2014 Oct; 86(4):378-89. PubMed ID: 25028482
[TBL] [Abstract][Full Text] [Related]
5. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
6. Sodium channel blockade may contribute to the analgesic efficacy of antidepressants.
Dick IE; Brochu RM; Purohit Y; Kaczorowski GJ; Martin WJ; Priest BT
J Pain; 2007 Apr; 8(4):315-24. PubMed ID: 17175203
[TBL] [Abstract][Full Text] [Related]
7. Block of persistent late Na+ currents by antidepressant sertraline and paroxetine.
Wang GK; Mitchell J; Wang SY
J Membr Biol; 2008 Mar; 222(2):79-90. PubMed ID: 18418539
[TBL] [Abstract][Full Text] [Related]
8. Benzonatate inhibition of voltage-gated sodium currents.
Evans MS; Maglinger GB; Fletcher AM; Johnson SR
Neuropharmacology; 2016 Feb; 101():179-87. PubMed ID: 26386152
[TBL] [Abstract][Full Text] [Related]
9. SSRI antidepressants differentially modulate serotonin reuptake and release in Drosophila.
Dunham KE; Venton BJ
J Neurochem; 2022 Sep; 162(5):404-416. PubMed ID: 35736504
[TBL] [Abstract][Full Text] [Related]
10. Functional Modulation of Na
Nakatani Y; Amano T
Biol Pharm Bull; 2018; 41(9):1471-1474. PubMed ID: 30175781
[TBL] [Abstract][Full Text] [Related]
11. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
[TBL] [Abstract][Full Text] [Related]
12. The pharmacogenetics of the selective serotonin reuptake inhibitors.
Brøsen K
Clin Investig; 1993 Dec; 71(12):1002-9. PubMed ID: 8124052
[TBL] [Abstract][Full Text] [Related]
13. Block of volume-regulated anion channels by selective serotonin reuptake inhibitors.
Maertens C; Droogmans G; Verbesselt R; Nilius B
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):158-65. PubMed ID: 12122503
[TBL] [Abstract][Full Text] [Related]
14. The Antidepressant Paroxetine Reduces the Cardiac Sodium Current.
Plijter IS; Verkerk AO; Wilders R
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768229
[TBL] [Abstract][Full Text] [Related]
15. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
Preskorn SH
Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
[TBL] [Abstract][Full Text] [Related]
16. Identification of WB4101, an
Li M; Wu Y; Zou B; Wang X; Li M; Yu H
Mol Pharmacol; 2018 Aug; 94(2):896-906. PubMed ID: 29884692
[TBL] [Abstract][Full Text] [Related]
17. Oxidation differentially modulates the recombinant voltage-gated Na(+) channel α-subunits Nav1.7 and Nav1.8.
Schlüter F; Leffler A
Brain Res; 2016 Oct; 1648(Pt A):127-135. PubMed ID: 27450927
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of cardiac and neuronal Na(+) channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine.
Stoetzer C; Papenberg B; Doll T; Völker M; Heineke J; Stoetzer M; Wegner F; Leffler A
Eur J Pharmacol; 2016 Jul; 783():1-10. PubMed ID: 27130441
[TBL] [Abstract][Full Text] [Related]
19. [Cardiovascular effects of selective serotonin reuptake inhibitor antidepressants].
Pacher P; Kecskeméti V
Orv Hetil; 2004 Feb; 145(8):425-31. PubMed ID: 15061027
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
Baumann P
Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
